The United States Patent and Trademark Office (USPTO) has received an intent-to-use trademark application (serial number 99130340) from SUBSENSE. The application seeks to trademark services related to non-invasive brain-computer interface (BCI) technology. These services include neurofeedback, cognitive enhancement, brain health monitoring, remote medical data monitoring for diagnosis and treatment, and medical consultation for treatment plans and cognitive rehabilitation.

This filing indicates a potential future market entry for BCI-based medical services. While this is a trademark application and not a regulatory rule, it signals emerging technologies in the healthcare sector. Compliance officers should be aware of the increasing use of BCI technology in medical applications, which may lead to future regulatory considerations regarding data privacy, patient safety, and medical device classification.